OpenTrons
Company

Last deal

$200M

Amount

Series C

Stage

23.09.2021

Date

8

all rounds

$240M

Total amount

General

About Company
OpenTrons is a developer of pipetting robot technology that automates experiments.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Opentrons Labworks

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company offers automated laboratory equipment that utilizes Python language, allowing scientific researchers to streamline and expedite their processes. With a range of products including lab robots, workstations, hardware modules, consumables, and labware, OpenTrons enables researchers to minimize human error while conducting experiments. As a disruptive life science company, Opentrons Labworks, Inc. leverages its integrated lab platform to accelerate innovation in research and healthcare. Through its business units, Opentrons Robotics and Neochromosome, the company provides flexible and user-friendly liquid handling lab robots for R&D operations and genome-scale cell engineering solutions for biopharma and biotech industries. Opentrons' open-source ecosystem empowers the scientific community to automate experiments, share protocols, and reproduce results, with their robots being utilized in numerous labs worldwide.